Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?

For example, would you feel comfortable offering APBI to an otherwise low risk patient in her 50s who did not have a SNB?

Answer from: Radiation Oncologist at Academic Institution

If the patient is otherwise a good candidate for APBI (age > 50, pT1 tumor, ER+, HER2 negative, Recurrence score low and intending to take endocrine therapy) that was clinically node negative and ultrasound axilla negative, I feel completely comfortable treating with APBI post lumpectomy with neg...

Comments

Radiation Oncologist at Valley Medical Center
Do you see value in treating with WBRT rather than...

Radiation Oncologist at Greater Baltimore Medical Center
I do.

Radiation Oncologist at South San Francisco Medical Center
Is ASTRO going to make a statement (analogous to A...

Radiation Oncologist at Allegheny Health Network, Pittsburgh
I agree with Dr. @White. I don't see a value in tr...

Answer from: Radiation Oncologist at Community Practice

Based on the EBCTCG RNI meta-analysis, DBCG, and MA.20, I would consider RNI in patients with central or medial tumors or those with T2 grade 3 disease. However, I've encouraged our surgeons to continue SLND, at least in patients aged 50-70. What should the primary outcomes be in INSE...

Comments

Radiation Oncologist at Allegheny Health Network, Pittsburgh
While all trials have limitations, I don't believe...

Please select the option that best describes you:

Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?

Related Questions